STAGE II LUNG CANCER AJCC V8

This study looked at the best dose of proton beam therapy (a precise type of radiation) when combined with standard chemotherapy for people with stage 2 or 3 non-small cell lung cancer that cannot be removed with surgery. 20 participants received different radiation doses to see …

This early-stage trial tested whether adding immunotherapy drugs (durvalumab, monalizumab, or oleclumab) to radiation therapy is safe for people with locally advanced non-small cell lung cancer that cannot be removed by surgery. Twenty-six participants received different combinat…

This phase II trial tested whether the immunotherapy drug pembrolizumab (Keytruda) can prevent lung cancer in 45 people with high-risk lung nodules or early-stage non-small cell lung cancer. Participants received pembrolizumab intravenously, and researchers tracked tumor response…

This early-phase study tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein that can fuel cancer growth. Researchers checked for side effects and m…

This study looked at heart changes in 24 people receiving radiation or chemo-radiation for lung or esophageal cancer that hadn't spread. Participants got a small heart monitor implanted to track heart problems that might otherwise go unnoticed. The goal was to better understand a…